Hali Biotechnology: Plans to establish a subsidiary and acquire equity from seven oral chain companies.

Haili Biotechnology announced that its holding subsidiary Ruisheng Biotechnology intends to jointly establish Jiangsu Haili Dental Medical Management Co., Ltd. with Zou Chunyang and Xie Shouliang with a registered capital of 15 million yuan, with Ruisheng Biotechnology holding 51% of the shares. After the establishment of Haili Dental and the completion of the acquisition and transfer of Ruisheng Biotechnology, it plans to acquire 100% equity of seven dental chain companies in Yangzhou and Changzhou held by Ruisheng Biotechnology. The transaction has been approved by the board of directors, does not constitute a related party transaction or a major asset restructuring. However, the acquisition of business changes and the registration procedures of the subsidiary have not been completed, and there are uncertainties.